Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (271-280 of 320) with videos related to

Pageof 32
Sort By:
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Genetics|April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesYi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical managementGianpaolo Suriano, Sandie Yew, Paulo Ferreira, et al.
The New England Journal of Medicine|May 11, 2017
Cancer-Associated Mutations in Endometriosis without CancerMichael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, et al.
The New England Journal of Medicine|June 12, 2009
Mutation of FOXL2 in granulosa-cell tumors of the ovarySohrab P Shah, Martin Köbel, Janine Senz, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
The New England Journal of Medicine|October 15, 2010
ARID1A mutations in endometriosis-associated ovarian carcinomasKimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, et al.
Cancer|March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special ConferenceRobert C Bast, Ursula A Matulonis, Anil K Sood, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Pageof 32

Showing results (271-280 of 320) with videos related to

Sort By:
Pageof 32
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Genetics|April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesYi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical managementGianpaolo Suriano, Sandie Yew, Paulo Ferreira, et al.
The New England Journal of Medicine|May 11, 2017
Cancer-Associated Mutations in Endometriosis without CancerMichael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, et al.
The New England Journal of Medicine|June 12, 2009
Mutation of FOXL2 in granulosa-cell tumors of the ovarySohrab P Shah, Martin Köbel, Janine Senz, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
The New England Journal of Medicine|October 15, 2010
ARID1A mutations in endometriosis-associated ovarian carcinomasKimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, et al.
Cancer|March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special ConferenceRobert C Bast, Ursula A Matulonis, Anil K Sood, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Pageof 32